论文部分内容阅读
目的:观察并分析β受体阻滞剂在临床抗心律失常治疗中的应用效果。方法:在本院2014年7月至2016年11月间收治的具有典型心律失常症状的病患中随机选取60例纳入此次研究,共设两组,各30例。对照组采用门冬氨酸钾镁片治疗,观察组则增加使用β受体阻滞剂(此次研究选择使用索他洛尔)治疗。结果:对比两组临床治疗总有效率,结果提示观察组有显著提高(P<0.05)。对比两组治疗后的心率变化情况,观察组也有显著降低(P<0.05)。治疗期间两组均未见明显不良反应。结论:在临床抗心律失常治疗中应用β受体阻滞剂可显著提高临床治疗效果,促进患者康复,故值得推广。
Objective: To observe and analyze the effect of β-blocker in the treatment of clinical anti-arrhythmia. Methods: Sixty patients randomly selected from our hospital from July 2014 to November 2016 with typical arrhythmia were enrolled in this study. There were two groups, 30 in each. The control group treated with potassium aspartate aspartate, while the observation group increased the use of beta blockers (the study chose to use sotalol) treatment. Results: Compared with the total effective rate of two groups, the results showed that the observation group was significantly increased (P <0.05). Comparing the changes of heart rate after treatment, the observation group also had a significant reduction (P <0.05). No significant adverse reactions were seen in both groups during treatment. Conclusion: The application of β-blockers in the treatment of clinical anti-arrhythmia can significantly improve the clinical effect and promote the recovery of patients, so it is worth promoting.